New care advice issued for cancer screening

High-Value Care Advice Provided for Cancer Screening
High-Value Care Advice Provided for Cancer Screening

(HealthDay News) -- High-value care advice has been provided for screening for five common types of cancer. The guidelines were published in the May 19 issue of the Annals of Internal Medicine.

Timothy J. Wilt, M.D., M.P.H., and colleagues from the High-Value Care Task Force of the American College of Physicians (ACP) reviewed screening strategies for asymptomatic, average-risk adults for five common types of cancer. The information was supplemented by findings from randomized controlled trials, modeling studies, and studies of costs or resource use.

According to the report, for breast cancer, all groups recommend mammography screening or discussions about screening for average-risk women aged 40 to 75 years at least every two years. For cervical cancer, all organizations recommend starting screening with cytology every three years at age 21 years, until age 65 years. For colorectal cancer, all organizations recommend screening with one of four strategies for persons aged 50 to 75 years. All organizations recommend against pelvic examination, cancer antigen 125 blood tests, and transvaginal ultrasonography for ovarian cancer screening. No organization recommends prostate-specific antigen testing unless benefits and harms are discussed and a patient expresses a clear preference for screening.

"The ACP strongly encourages clinicians to adopt a cancer screening strategy that focuses on reaching all eligible persons with these high-value screening options while reducing overly intensive, low-value screening," the authors write.

Clinical Guideline
Value Framework

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs